Trademark Overview
On Thursday, July 8, 2021, a trademark application was filed for DEMMUNIZATION with the United States Patent and Trademark Office. The USPTO has given the DEMMUNIZATION trademark a serial number of 90818079. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, October 18, 2022. This trademark is owned by CANOPY IMMUNO-THERAPEUTICS LTD.. The DEMMUNIZATION trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the antibody creation and antigen specific immune response in autoimmune, Allergic and inflammatory diseases; Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen specific imm...
